PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
26-Aug-2022 PureTech Health – Half-Year Report PureTech
26-Aug-2022 Essential Pharma strengthens its global operating platform in preparation for next stage of growth Essential Pharma
26-Aug-2022 Cellefill™, a new integrated solution to fast-track cell, gene and biological therapies Flexicon Liquid Filling
26-Aug-2022 Byondis Initiates Phase I Study of Next Generation Antibody-Drug Conjugate BYON3521 Byondis
26-Aug-2022 Zelluna Immunotherapy announces investment from Takeda Ventures, Inc. Zelluna Immunotherapy
26-Aug-2022 Freya Pharma Solutions Announced Further Strengthening of its IP Position for Improved Treatment for Women Suffering From FSIAD Freya Pharma Solutions
26-Aug-2022 The PCMG Annual Assembly goes Climate Positive thanks to Veramed and Earthly Veramed
26-Aug-2022 Shortlist Announced For Inaugural Sustainable Medicines Packaging Awards YewMaker and Connect In Pharma
25-Aug-2022 KU Leuven spin-off AstriVax raises € 30 million to build vaccine platform KU Leuven
25-Aug-2022 Sonde Health Inks Multi-Year Partnership with Koye Pharmaceuticals PureTech
25-Aug-2022 AVer Europe enters healthcare market with launch of Connected Health Solutions AVer Europe
25-Aug-2022 The future of MedTech is in the past Snedden Campbell
25-Aug-2022 AMPAC FINE CHEMICALS ANNOUNCES EXPANSION OF CAPABILITIES IN CALIFORNIA AMPAC Fine Chemicals (AFC)
25-Aug-2022 Asklepios Kliniken: Stable development continues in H1 2022 Asklepios Kliniken
25-Aug-2022 Evotec expands clinical and commercial drug substance manufacturing with acquisition of Central Glass Germany Evotec SE
25-Aug-2022 Evolva with record half-yearly sales and new mid-term plan Evolva Holding SA
24-Aug-2022 AEVIS VICTORIA SA – AEVS.SW: Revenues up by 42.6% to CHF 584.2 million (2021: CHF 409.8 million) in the first semester of 2022 AEVIS VICTORIA SA
24-Aug-2022 Cellefill™, a new integrated solution to fast-track cell, gene and biological therapies Sciad Newswire
24-Aug-2022 AEVIS VICTORIA SA – AEVS.SW: Revenues up by 42.6% to CHF 584.2 million (2021: CHF 409.8 million) in the first semester of 2022 AEVIS VICTORIA SA
24-Aug-2022 Relief Therapeutics files registration statement on form F-1 with the U.S. Securities and Exchange Commission Relief Therapeutics Holding SA